Overview

Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease

Status:
Not yet recruiting

Trial end date:
2025-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this multi-centered, NIH-sponsored study is to to develop an optimal protocol for using noninvasive 129Xe gas exchange MRI to detect changing disease activity in interstitial lung diseases (ILDs).

Phase:

Phase 2

Details

Lead Sponsor:

Bastiaan Driehuys

Collaborators:

Children's Hospital Medical Center, Cincinnati
National Heart, Lung, and Blood Institute (NHLBI)
University of Cincinnati
University of Iowa
University of Wisconsin, Madison